ReviewPharmaceuticals (Basel, Switzerland)2025

Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.

Syed Arman Rabbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.